Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis

At 3.0 T, use of a gadolinium-based contrast material at follow-up MRI did not change the diagnosis of interval disease progression in patients with multiple sclerosis.